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T lymphocytes’ ability to discriminate between struc-
turally related antigens has been attributed to the
unique signaling properties of the T cell receptor.
However, recent studies have suggested that the
output of this discrimination process is conditioned
by environmental cues. Here, we demonstrate how
the IL-2 cytokine, collectively generated by strongly
activated T cell clones, can induce weaker T cell
clones to proliferate. We identify the PI3K pathway
as being critical for integrating the antigen and cyto-
kine responses and for controlling cell-cycle entry.
We build a hybrid stochastic/deterministic computa-
tional model that accounts for such signal synergism
and demonstrates quantitatively how T cells tune
their cell-cycle entry according to environmental
cytokine cues. Our findings indicate that antigen
discrimination by T cells is not solely an intrinsic
cellular property but rather a product of integration
of multiple cues, including local cues such as antigen
quality and quantity, to global ones like the extracel-
lular concentration of inflammatory cytokines.
INTRODUCTION
Self/non-self discrimination by T lymphocytes is a critical func-
tion of the adaptive immune system for eradicating pathogen-
infected tissues while sparing uninfected tissues. Such discrim-
ination is also at play when T cells rely on their ability to detect
‘‘altered self’’ and eradicate tumors (Houghton and Guevara-
Patin˜o, 2004). Quantitative models of ligand discrimination by
T cells dwell on the dynamics of signal transduction (Feinerman
et al., 2008a). The premise for these models is the experimental
observation that the potency of antigen ligands correlates with
the lifetime of their complex with the T cell receptor (TCR). Minute1208 Cell Reports 11, 1208–1219, May 26, 2015 ª2015 The Authorsdifferences in these complex lifetimes—as documented experi-
mentally (Huppa et al., 2010; Liu et al., 2014)—are amplified
through kinetic proofreading (McKeithan, 1995), through me-
chanical sorting (Liu et al., 2014; Qi et al., 2001), or through dif-
ferential activation of positive/negative feedbacks (Altan-Bonnet
and Germain, 2005; Franc¸ois et al., 2013). Ultimately, models of
such dynamic sorting of the quality of the antigen/TCR interac-
tion account for the speed, sensitivity, and specificity of T cell
activation, with the additional insight about the existence of
antagonism by sub-threshold ligands (Altan-Bonnet and Ger-
main, 2005; Franc¸ois et al., 2013) and the origin of phenotypic di-
versity because of endogenous variability in the abundance of
key signaling regulators (Feinerman et al., 2008b).
Antigen discrimination by T cells has been considered mostly
as the intrinsic response of individual cells. However, recent
studies have demonstrated that the threshold of T cell activation
can be modulated (Slifka and Whitton, 2001), in particular when
environmental cues are added (McNally et al., 2011; Pipkin et al.,
2010; Richer et al., 2013; Williams et al., 2006). Hence, antigen
discrimination may not be cell intrinsic per se but rather collec-
tively tunable by cytokines and chemokines produced by neigh-
boring cells (Richer et al., 2013). Such insight would open ave-
nues to manipulate the repertoire of T cell clones responding
to an infection or to tumors. A specific example is a study where
ablation of the regulatory T cell compartment led to the enlarge-
ment of the repertoire of responding cells, recruiting additional
clones of weaker affinity for the antigen to the adaptive immune
response against infection (Pace et al., 2012). Hence, rather than
a set threshold of activation for each T cell (Au-Yeung et al.,
2014), integration of environmental cues may lead to fine tuning
the response to antigens, raising the possibility that co-respond-
ing T cells could modulate each other’s responses, either nega-
tively through competition for limited cytokines or chemokines
(Busse et al., 2010; Feinerman et al., 2010; Pace et al., 2012)
or positively through synergy between antigen and chemokine/
cytokine signaling (Pace et al., 2012; Richer et al., 2013)
Here, we explore how the strong antigen response of CD8+
T cells impact the activation of neighboring weaker clones
(a process akin to co-optation in decision making). We demon-
strate a critical role for IL-2 as a cytokine whose accumulation
and sensing by T cells add to the signaling response of the
TCR, enabling full and complete activation despite a sub-
threshold response to antigen. Strong activation of few T cell
clones generates sufficient IL-2 to co-opt a fraction of weaker
clones into activation. We identify cumulative PI3K activation
as the dominant molecular mechanism controlling cell-cycle en-
try through integration of TCR and IL-2 receptor (IL-2R) signals.
To understand quantitatively how IL-2 modulates cell-cycle
entry for weakly stimulated cells, we developed an experimen-
tally parametrized computational model of the integration of
TCR and IL-2R signals. Such modeling approach has recently
provided valuable insights about different functions of the im-
mune system, with theoretical efforts addressing how the TCR
signaling machinery achieves ligand discrimination (Franc¸ois
et al., 2013; Stepanek et al., 2014), how T cells regulate their dif-
ferentiation and cell lineage commitment (Buchholz et al., 2013;
Gerlach et al., 2013; Schulz et al., 2009), how populations of
T cells respond collectively to antigens and cytokines (Hart
et al., 2014; Tkach et al., 2014), etc. Computational models of
the immune response serve three purposes: (1) testing the suffi-
ciency of our biological understanding; (2) tackling the combina-
torial and dynamic complexity of immune regulations; and (3)
designing new perturbations for immunotherapeutic manipula-
tions. The strength of these recent modeling efforts resides in
their experimental parametrization, enhancing the biological
relevance of their results and leading to explicit predictions
that can be tested experimentally.
Here, using ourmodel of integration of local TCR and global IL-
2R signals, we demonstrate that non-linear signal transduction
coupled to the inherent stochasticity of the processes regulating
gene expression accounts for the observed heterogeneity of first
division times in response to IL-2. We also predict and confirm
experimentally how entry into cell cycle is modulated by IL-2 sig-
nals and is strongly dependent on antigen affinity and availability.
Extending our model to the context of duoclonal populations of
T cells, we further predict and experimentally confirm how co-
optation of weaker clones depends on cell density and antigen
availability. Finally, we investigate how regulatory T cells (T-reg
cells) can regulate the co-optation of weaker clones based on
their consumption of IL-2 and discuss potential applications for
clinical immunotherapies.
RESULTS
Inter-clonal Co-optation among CD8+ T Cells Depends
on TCR Signal Strength
To investigate the possible interdependencies within a poly-
clonal population of T cells, we used two well-characterized
CD8+ TCR transgenic T cells, namely the OT-1 and P14 cell
clones. Each T cell clone expresses a TCR with high affinity for
a specific agonist ligand, a peptide (SIINFEKL, denoted as N4
for OT-1 cells; KAVYNFATM, denoted as GP33–41 for P14 cells)
presented by a particular subset of MHC-I molecule (H-2Kb for
N4 and H-2Db for GP33–41) on the surface of antigen-presenting
cells (APCs). We isolated TCR-transgenic T cells from the spleen
of naive OT-1 and P14 mice and co-cultured these two T cellCpopulations in the same wells. To ensure that antigen presenta-
tion was minimally affected by the presence of the other cell
type, we used distinct sets of APCs to present the ligands spe-
cific for each cell type (Figure 1A). Wemonitored the proliferation
of each cell type simultaneously by monitoring with single-cell
resolution the dilution of an amine reactive dye (CTV for OT-1
cells and CFSE for P14 cells). This proliferation assay allows
one to track the number of divisions a given cell has undergone
until the time of observation (Figure 1B). Specifically, we tested a
set of altered peptide ligands for OT-1 T cells (Zehn et al., 2009)
with varying capacities to stimulate. We observed that, although
most of the OT-1 cells (>96%) proliferated when stimulated by
the agonist antigen (H-2Kb/N4), only 25% of OT-1 cells divided
when they were stimulated by equivalent quantities of the
H-2Kb/G4 variant (Figures 1C and 1D). Surprisingly, the percent-
age of OT-1 cells to proliferate under G4 stimulation increased
(to more than 60%) when co-cultured P14 cells were simulta-
neously activated in the same culture milieu. In contrast, OT-1
cells stimulated by the agonist N4 were largely indifferent to
the activation status of the co-cultured P14 cells, with close to
98% of OT-1 cells entering the cell cycle (Figures 1C and 1D).
Hence, the vicinity of activated P14 cells could co-opt weakly
activated neighboring T cells that would otherwise fail to enter
the cell cycle and proliferate.
IL-2 Mediates the Inter-clonal Co-optation of Weakly
Stimulated CD8+ T Cells
To investigate the signaling mechanism co-opting weakly stimu-
lated T cells, we repeated the experiments described in Figure 1B
and further inhibited JAK kinases (whose activation is critical for
the response to extracellular cytokines): we found that JAK inhi-
bition entirely abrogated the co-optation from P14 cells (Figures
1C and 1D). This strongly suggested that soluble factors (i.e.,
cytokines activating the JAK/STAT pathway) play a major role
in this inter-clonal co-optation. We therefore tested directly the
impact of different cytokines including IL-2, IL-4, IL-6, IL-7, IL-
9, IL-15, IL-21, and IFN-g on the activation of OT-1 T cells stim-
ulated with the weak agonist G4. We found that, among all the
cytokines tested, only IL-2 and IL-4 were able to substantially
co-opt weakly stimulated CD8+ T cells and increase the fraction
of OT-1 precursor cells that entered cell cycle (Figure 1E). It is
important to note here that other cytokines, such as IL-7, main-
tained cell viability as well as IL-2 and IL-4, but they could not
trigger entry into the cell cycle on their own (see Figure S1). Titra-
tions of IL-2 and IL-4 revealed slightly different effects of these
cytokines on cycle entry and survival: whereas IL-2 was found
to be more efficient in triggering cell-cycle entry, IL-4 could sus-
tain cell viability better than IL-2 (see Figure S1).
We next tested whether the candidate cytokines IL-2 or IL-4
could be responsible for the co-optation of weak T cell clones
in co-culture settings. We used antibody blockade to specifically
inhibit the effects of IL-2 or IL-4 in the co-culture. We found that,
whereas the co-optation of weakly activated OT-1 was unaltered
when IL-4 was blocked, IL-2 blockade abrogated this co-opta-
tion almost entirely (Figure 1F). We confirmed the importance
of IL-2 signaling as a key mediator of the inter-clonal co-optation
using a blocking antibody against IL-2Ra, the a subunit of the IL-
2R (also named CD25). Other studies suggested that CCL3/4/5ell Reports 11, 1208–1219, May 26, 2015 ª2015 The Authors 1209
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Figure 1. The Inter-clonal Co-optation of Weakly Activated CD8+ T Cells Is Dependent on IL-2
(A) Two different TCR transgenic CD8+ T cell populations (P14 and OT-1) were labeled with different amine reactive dyes (CFSE and CTV, respectively) and
stimulated in vitro with specific antigens presented by distinct APCs.
(B) Tracking of the proliferation of the two different T cell populations by flow cytometry using the dilution of a fluorescent amine reactive dye (CFSE for P14 cells
and CTV for OT-1 cells). We present one representative dot plot of CFSE and CTV MFI for live CD8+ cells after 3 days of co-culture. At each cell division, the
amount of the amine reactive dye per cell is divided uniformly by a factor 2 among daughter cells, which allows one to track the number of divisions experienced
by a given cell until the time of observation and to estimate the number of divisions performed by precursor cell.
(C and D) Activated P14 cells co-opt only weakly stimulated OT-1 cells, and this is conditioned upon JAK signaling. (C) Distributions of the number of cell divisions
per OT-1 precursor cells are measured after 3 days in the in vitro co-culture system presented in (A) and (B). OT-1 cells were stimulated with Kb MHC loaded with
either a strong (N4, peptide sequence: SIINFEKL) or a weak agonist (G4, peptide sequence: SIIGFEKL). For each condition of stimulation for the OT-1 cells, the
co-cultured P14 cells were either not stimulated (‘‘no co-optation’’ condition) or stimulatedwith their cognate antigen GP33–41 (‘‘with co-optation’’ condition) in the
presence or absence of a JAK inhibitor (AZD1480; 1 mM). (D) Percentages of OT-1 precursor cells that divided are reported for the experiment shown in (C). Error
bars represent mean ± SD for three replicates; the results are representative of nR 3 independent experiments.
(E) Effect of the addition of different cytokines on the proliferation of OT-1 cells stimulated with the weak agonist Kb/G4 in the absence of co-opting P14 cells. A
given dose of cytokine (1 nM) was added at time t = 0, and the number of OT-1 precursors that divided was estimated after 3 days. Error bars represent mean ±SD
for three replicates; the results are representative of nR 3 independent experiments. Among the cytokines tested, IL-2 and IL-4 were found to be the only ones to
allow a significant fraction of weakly stimulated OT-1 cells to proliferate.
(F) IL-2 and not IL-4 is responsible for the co-optation of OT-1 cells by P14 cells. OT-1 cells were stimulated with a weak agonist (Kb/G4) in the presence of P14
cells left either unstimulated (no co-optation) or stimulated by their cognate antigen Db/GP33-41 (with co-optation). Blocking antibodies against mouse IL-2 (clone
JES6-1A12) and IL-4 (clone 11B11) were added at time t = 0 to identify the cytokines mediating the co-optation of OT-1 cells. The effect of IL-2 blockade was
confirmed using a blocking antibody against the alpha subunit of the IL-2 receptors (CD25; clone PC61.5). Error bars represent mean ±SD for three replicates; the
results are representative of nR 3 independent experiments.
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Figure 2. IL-2Modulation of Cell Cycle Entry
Relies on PI3K Activation and Is Indepen-
dent of MAPK Activity
(A) Schematic representation of the signaling
pathways downstream of the TCR and the IL-2R.
The different phospho-species measured are
indicated by black stars. Inhibitors used here are
represented next to their target.
(B) Effect of small-molecule inhibitors on IL-2
signaling. We report the GMFI of the phospho
signals indicated in OT-1 T cell blasts left un-
stimulated or stimulated with 1 nM IL-2 at 37C for
15min in the presence of different inhibitors (MEKi,
1 mM; JAKi, 1 mM; PI3Ki, 3 mM). Error bars repre-
sent mean ± SD for three replicates; the results are
representative of nR 3 independent experiments.
(C and D) Effect of IL-2 and small-molecule in-
hibitors on the proliferation of OT-1 CD8+ T cells
stimulated with antigens of varied strength (N4 >
T4 > G4). Cells were cultured for 3 days in the
presence of a blocking antibody against the
endogenous mouse IL-2 (clone JES6-1A12) either
alone (‘‘No Cyt’’) or with the addition of an initial
dose (1 nM) of human IL-2 and different inhibitors
(MEKi, 1 mM; JAKi, 1 mM; PI3Ki, 10 mM). We report
the histogram of the CTV GMFI (C) and the per-
centage of OT-1 precursor cells (D) that divided for
the experiment shown in (C). Note that, for reasons
of readability, histograms corresponding to stim-
ulations in absence of IL-2 and in the presence of
inhibitors are not shown in (C). Error bars represent
mean ± SD for three replicates; the results are
representative of nR 3 independent experiments.chemokines were possible mediators of the activation of low-af-
finity clones in vivo (Pace et al., 2012); however, in our experi-
mental in vitro settings, we found that the initial addition of these
chemokines could not trigger proliferation of weakly stimulated
clones (Figure S1). Moreover, blocking CCL3/4/5 chemokines
did not abrogate the co-optation of weakly stimulated clones
when co-cultured with strongly stimulated neighboring P14 cells
(Figure S1). Therefore, in our experimental in vitro settings, the in-
ter-clonal boost to entrain weak T cell clones into proliferation is
mediated by soluble IL-2 secreted by neighboring cells.
We further investigated when IL-2 can synergize with TCR sig-
nals to drive cell-cycle entry for T cell responding toweak antigen
stimulation. We delayed the addition of IL-2 after the initial stim-
ulation by weak agonists and found that IL-2 is needed in the first
20–30 hr following antigen stimulation (Figure S1). Using IL-7 as a
factor promoting survival without triggering cell-cycle entry (see
Figures 1E and S1), we demonstrated that the early requirement
for IL-2 for cell proliferation was independent of cell death
(Figure S1).Cell Reports 11, 1208–121To confirm the activation status of
weakly stimulated CD8+ T cells in pres-
ence of IL-2, wemeasured the expression
of surface activation markers CD44 and
CD69, transcription factors Tbet and
Eomes, as well as production of IL-2
and IFN-g and found them comparableto that of strongly stimulated cells proliferating without external
IL-2 (Figure S2). Thus, co-optation of weakly stimulated T cells
in presence of IL-2 leads to a full and complete activation similar
to that of strongly activated cells, albeit at lower frequency. Our
results therefore demonstrate that sensing of IL-2 in the first
hours following antigen encounter can trigger the complete acti-
vation of a fraction of weakly stimulated T cells.
IL-2 Signaling Contributes to Cell Cycle Entry through
PI3K Activation
Next, we sought to identify the molecular mechanisms by which
IL-2 signaling contributes to cell-cycle entry for weakly activated
CD8+ T cells. We first combined the use of small-molecule inhib-
itors to target several signaling pathways, namely the JAK-STAT,
MAPK, and PI3K-AKT-mTOR pathways, downstream of the TCR
and IL-2R and measurements of the abundance of phosphory-
lated species implicated in the activation of these pathways (Fig-
ure 2A). Phosphorylation of STAT5 was used as a control for
IL-2R stimulation. MEK1/2 and PI3K inhibition did not affect9, May 26, 2015 ª2015 The Authors 1211
STAT5 phosphorylation following IL-2R engagement whereas,
as expected, it was entirely abrogated by JAK inhibition (Figure
2B). As previously reported (Brennan et al., 1999; Cho et al.,
2013), we observed that both S6 ribosomal protein (denoted
as S6) and ERK1/2 (noted ERK) were phosphorylated after IL-2
stimulation. Although S6 is reported as a target for activated
ERK (Wang et al., 2001), MEK1/2 inhibition did not abrogate
IL-2-mediated phosphorylation of S6. Instead, PI3K inhibition
efficiently prevented S6 phosphorylation without affecting ERK
phosphorylation after IL-2 stimulation (Figure 2B). In line with
previous results demonstrating the importance of S6 activation
by PI3K in the control of cell-cycle progression (Brennan et al.,
1999), our signaling results suggested a critical role for PI3K acti-
vation in mediating IL-2 impact on cell-cycle progression in the
context of weak TCR stimuli.
To confirm this at the functional level, we used the proliferation
assay presented above. We stimulated OT-1 T cells with anti-
gens of different affinities for the TCR (H-2Kb-expressing cells,
loaded with N4, T4, and G4 peptides, in descending order of an-
tigenicity) in the presence or absence of IL-2 and inhibition of the
pathways under consideration (Figure 2A). CD8+ T cells acti-
vated by a TCR agonist produce endogenous IL-2. To ensure a
uniform amount of IL-2 across the different conditions, we took
advantage of the fact that IL-2 from human origin is as potent
a ligand for murine IL-2R as the endogenous IL-2 (Deenick
et al., 2003). We could therefore control the amount of total
IL-2 in the culture by using an antibody that blocked specifically
secreted murine and not human IL-2 and by dispensing a fixed
concentration of human IL-2.
As anticipated from the previous observation that OT-1 cells
receiving strong TCR stimuli (Kb/N4) were insensitive to any
co-optation from co-cultured P14 T cells, the addition of external
IL-2 or inhibition of JAK had little impact on their proliferation
(Figures 2C and 2D). In contrast, inhibition of MAPK and PI3K
both affected the percentage of cells that divided after stimula-
tion with Kb/N4. Addition of external IL-2 could only rescue the
proliferation of cells treated with a MEK1/2 inhibitor and not
with a PI3K inhibitor (Figures 2C and 2D).
In comparison to these strong TCR stimuli, intermediate TCR
stimuli (Kb/T4) induced a lower percentage of cells to divide in
the absence of IL-2 and the addition of external IL-2 was found
to increase this percentage. Similarly to the Kb/N4 case, the
impact of MEK1/2 and not of PI3K inhibition could be rescued
with the addition of IL-2.
In the case of weak TCR stimuli (Kb/G4), proliferation was only
observed in the presence of IL-2 (Figures 2C and 2D). In line with
our results with short-term signaling assays (Figure 2B), inhibi-
tion of JAK and PI3K abrogated the effect of IL-2 whereas inhibi-
tion of MEK1/2 was insignificant in terms of cell-cycle entry. We
also measured the upregulation of the IL-2Ra receptor subunit in
the presence of IL-2 under PI3K inhibition (at an inhibitor dose for
which entry into cell cycle was blocked; Figure S3), but not under
JAK inhibition: this demonstrated that IL-2R upregulation was
mediated by the JAK-STAT pathway and was largely indepen-
dent of PI3K activity. Our experiments thus delineated the over-
lapping signaling responses downstream of TCR and IL-2R:
initial TCR signals are critical to drive IL-2Ra expression, which
in turn enables IL-2 responsiveness and further PI3K activation.1212 Cell Reports 11, 1208–1219, May 26, 2015 ª2015 The AuthorsSuch PI3K activation then acts as the integration point between
the TCR and IL-2 pathways controlling the entry into cell cycle for
weakly stimulated CD8+ T cells in the presence of IL-2.A Hybrid Stochastic/Deterministic Model Recapitulates
the Distribution of First Division Times and Its
Modulation by IL-2
Our previous results indicate that IL-2 can modulate cells’ deci-
sion to enter cell cycle through the activation of the PI3K-AKT-
mTOR pathway. We found that this decision to enter the cell
cycle was highly heterogeneous, even within isogenic popula-
tions of cells: after 3 days in the presence of IL-2, a fraction of
weakly stimulated cells underwent up to five cell divisions
(>20%) whereas others had not started to divide (Figure 2D).
To understand the origin of this divergence of cell fates—be-
tween entering the cell cycle or not (Au-Yeung et al., 2014)—
and the tuning role of IL-2, we developed a quantitative model
that bridges the different time scales of the events occurring dur-
ing the first days following antigen encounter (Figure 3A; see
Supplemental Experimental Procedures and Figure S4 for a
complete definition of the model). We modeled the activation
of T lymphocytes at the individual cell level by modeling the
signaling responses downstream of the TCR and IL-2R. Engage-
ment of these receptors in turn activates transcription factors
that regulate the expression of cytokine, cytokine receptors,
and CyclinD (a critical regulator of cell-cycle entry).
To account for the observed phenotypic variability in cell-cycle
entry,we implementedamixeddeterministic/stochasticmodeling
framework. We reasoned that signaling responses occur on fast
timescales (min) using large number of proteins (e.g., 30,000 re-
ceptors for theantigen): thesecouldbemodeledwith steady-state
approximationsor deterministic ordinary differential equations. As
far as transcriptional responses are concerned, their slow dy-
namics and the low copy number of mRNA (e.g., for IL-2Ra and
CyclinD) necessitate a stochastic treatment. Such stochasticity
generates cell-to-cell variability that may account for heterogene-
ity in cell-cycle entry within isogenic population of cells.
From our theoretical point of view, themodulation of cell-cycle
entry by IL-2 can be best understood by considering the two
‘‘extreme’’ regimes:
(1) In the absence of IL-2, the constant presence of a strong
agonist antigen (characterized by a long half-life of bind-
ing with the TCR; t = 10 s) leads to an equilibrium distribu-
tion for IL-2Ra peaked at a finite value close to its mean
value set to 103 copies per cell (Figures 3B and S2). For
a weaker agonist (t = 1 s), this equilibrium distribution is
shifted toward smaller values. Importantly, even though
its mode corresponds to null expression of IL-2Ra, indi-
cating that the most probable number of IL-2Ra mole-
cules per cell at any given time is zero, the tail of this
distribution is long and a fraction of cells also express
amounts of IL-2Ra similar to those obtained with a strong
agonist (see experiments in Figure S2).
(2) Conversely, in the absence of antigen and in the condition
where the level of IL-2 is maintained constant, the mean
value of IL-2Ra reached at equilibrium depends on the
constant amount of IL-2 provided. Without IL-2, the basal
BC D
A Figure 3. A Hybrid Computational Model for
the Regulation of Cell Cycle Entry through
the Integration of TCR and IL-2R Signals
Exhibits a Bistable Behavior
(A) Schematic representation of the hybrid quan-
titative model for the interplay between TCR and
IL-2 signaling in the regulation of cell-cycle entry.
Events occurring on short timescales, such as
phosphorylations, are treated as deterministic,
and we assume quasi-equilibrium for the corre-
sponding variables. Events occurring on long
timescales, such as gene transcription and mRNA
translation, are treated as stochastic (green ar-
rows). For weakly TCR stimulated cells, variability
in the expression of the IL-2 receptor (IL-2Ra)
ensures that only a fraction of them express a
sufficient amount of the receptor to efficiently
trigger the (IL-2Ra+IL-2) > (pSTAT5) > (IL-2Ra)
positive feedback loop (highlighted in red), leading
to a (IL-2Ra)-high state and further activating PI3K
and allowing the subsequent entry into the cell
cycle.
(B) IL-2Ra production and degradation rate as a
function of IL-2Ra in the absence of antigen (upper
panel). In the presence of a constant dose of IL-2,
the (IL-2Ra+IL-2) > (pSTAT5) > (IL-2Ra) positive
feedback loop (highlighted in red in A) leads to the
co-existence of two stable equilibrium points (high
and low represented as solid black circles) sepa-
rated by an intermediate unstable point (repre-
sented as a solid red circle). A cell expressing
more (resp. less) IL-2Ra than this intermediate
level (represented by the vertical gray line) will
eventually reach the high (resp. low) stable state.
We report the equilibrium distributions of IL-2Ra
levels in absence of IL-2 for constant levels of two
antigens with different affinities for the TCR (a
weak agonist, t = 1 s, and a strong agonist, t = 10
s). Dots are results of the stochastic simulation,
and solid lines are theoretical distributions ob-
tained as described in Friedman et al. (2006). In
the case of the weak agonist in the presence of a
given dose of IL-2 and at a given time, only a
fraction of cells are above the intermediate un-
stable IL-2Ra level (vertical gray line).
(C) Time evolution of the number of CyclinD
molecules for five different cells in the case of a
stimulation by a weak agonist (t = 1 s) at time t = 0, without IL-2, or in the presence of an initial dose of IL-2 (1 nM). Cell-cycle entry happens when the number of
CyclinD molecules accumulated in the cell overcomes a fixed threshold (represented by the black dashed line). Time of the first division is denoted as ‘‘tstart’’.
(D) Simplified representation of the model behavior under different stimulatory conditions (with low/high affinity antigen in the presence or absence of IL-2).
Weakly stimulated cells rely on the presence of IL-2 to activate PI3K and subsequently enter cell cycle. The presence of a bi-stable module ensures that only a
fraction of weakly stimulated cells (those reaching the high stable state) enter cell cycle. For cells stimulated through their TCR with a strong agonist, PI3K is
efficiently activated downstream of the TCR. Hence, additional inputs from engaged IL-2 receptors have little impact on the overall PI3K activity and on the
subsequent entry into cell cycle.rate of transcription of the il-2ra gene provides a unique
stable equilibrium point with only a few IL-2Ra molecules
per cell (Figure 3B). In the presence of a sufficient amount
of IL-2, another stable equilibrium point exists with a large
number of IL-2Ra molecules per cell. Given the depen-
dency of IL-2 signaling on IL-2Ra abundance (Cotari
et al., 2013), as illustrated in Figure S5, these two stable
equilibrium points can coexist for an intermediate dose
of IL-2 and are separated by an unstable equilibrium point
for intermediate abundances (IL-2Ra*300 for [IL-2] = 10CpM). Accordingly, in this particular case, a cell with an
abundance of IL-2Ra greater (resp. smaller) than IL-
2Ra* will eventually reach the high IL-2Ra (resp. low
IL-2Ra) stable equilibrium point.
We used our model to probe the more-realistic regime when
both the availability of antigen and IL-2 are dynamically regu-
lated: at any given time, the quantity of IL-2Ra expressed by a
cell and the amount of available IL-2 set a tendency to evolve to-
ward one or the other equilibrium state. In the high-equilibriumell Reports 11, 1208–1219, May 26, 2015 ª2015 The Authors 1213
AB
Figure 4. The Model for CD8+ T Cell Activation Recapitulates IL-2 Modulation of Cell Cycle Entry
(A) Comparison between the experimental and theoretical distributions of first division times tstart. Experiments: OT-1 T cells were stimulated with antigens of
varied strength (Kb/N4 and Kb/G4) and cultured for 3 days in the presence of a blocking antibody against the endogenous mouse IL-2 (clone JES6-1A12) either
alone or with the addition of an initial dose (1 nM) of human IL-2. The cumulative distribution of first division times was computed from the GMFI of the amine
reactive dye CTV, assuming a constant doubling period of 10 hr. Model: for each condition, we simulated independently 103 different cells stimulated by aweak or
a strong antigen (t = 1 s or t = 10 s) at time t = 0, without IL-2, or in the presence of an initial dose of IL-2 (1 nM).
(B) Representation of the percentage of OT-1 precursor cells that divided as a function of antigen quality and antigen quantity. Experiments: OT-1 T cells were
stimulated with APCs pulsed with antigens of varied strength (from E1 to N4) at various concentrations and cultured for 3 days in the presence of a blocking
antibody against the endogenousmouse IL-2 (clone JES6-1A12) either alone (condition 1: ‘‘no IL-2,’’ left) or with the addition of an initial dose (1 nM) of human IL-2
(condition 2: ‘‘+IL-2’’ condition, center). The difference between these two conditions is represented on the panel on the right. Model: for each condition, we
simulated independently 103 different cells stimulated by APCs presenting 10 to 105 ligands (parameter Ag) of a given affinity for the TCR (parameter t) at time
t = 0, without IL-2, or in the presence of an initial dose of IL-2 (1 nM).state, signals transmitted through the IL-2R are at a maximum
and PI3K is efficiently activated. In the case of stimulation with
a weak agonist (t = 1 s), the occasional bifurcations toward the
high-equilibrium point in the presence of IL-2 allow enough
PI3K activation to efficiently accumulate CyclinD molecules1214 Cell Reports 11, 1208–1219, May 26, 2015 ª2015 The Authorsand to eventually cross the threshold for cell-cycle entry (Figures
3C and 3D) as observed experimentally (Figure S2).
The proposed model reproduced accurately the experimental
distribution of first division times for strong and weak agonists in
the presence or absence of IL-2 (Figure 4A). For strong agonists
(t = 10 s), PI3K activation is initially dominated by signals gener-
ated by the TCR and CyclinD is efficiently accumulated without
any need for additional inputs from the IL-2R (Figure 3D). For
weak agonists (t = 1 s), initial TCR signals fail to generate enough
CyclinD on their own and crossing of the CyclinD accumulation
threshold necessitates PI3K activation through IL-2 signals.
Our model for TCR signaling (Franc¸ois et al., 2013) indicates
that low presentation of strong agonists results in proximal
TCR signals comparable in strength to those obtained with a
large quantity of weak agonists. As such, our global model for
the integration of TCR and IL-2R signals predicted that IL-2
should also modulate cell-cycle entry for cells stimulated with
low quantities of strong agonists and more generally with weak
TCR signals. Such quantitative predictions were accurately veri-
fied experimentally by titrating the presentation of a number of
peptide variants with different affinities for the OT-1 TCR, namely
E1, G4, V4, T4, Q4, and N4 in ascending order, in the presence or
absence of exogenous IL-2 (Figure 4B). All together, our compu-
tational model accounts for the impact of local (antigen-based)
and global (IL-2-derived) cues that T cells must integrate to
decide whether to enter cell cycle or not.
Inter-clonal Co-optation within a Population of T
Lymphocytes Is Modulated by Cell Density, Antigen
Availability, and Presence of T-reg Cells
We then derived quantitative predictions from our computational
model to test how variable co-optation of weakly stimulated
T cells is. Experimentally, weobserved that co-optation ofweakly
stimulated T cells depended not only on the total quantity of IL-2
(Figure S1) available but also on the timing of IL-2 presence (Fig-
ureS1).Ourmodel for global IL-2 accumulation predicted that the
duration of IL-2 availability above a certain concentration and the
amount of accumulated IL-2 depended on many parameters,
including the number of initial precursors, antigen availability,
and the introduction of IL-2 competitors consuming the shared
resource (Figure S5). To test this prediction experimentally, we
investigated how the density of co-opting P14 cells and the pres-
ence of IL-2-consuming cells (e.g., CD4+CD25+ regulatory
T cells a.k.a. T-reg cells) impacted the inter-clonal co-optation
of weakly stimulated T cells. We isolated T-reg cells from wild-
type splenocytes and included them in our in vitro co-culture sys-
tem (Figure 5A). As detailed above, we tracked the number of cell
division experienced by both the co-opting P14 cells and the
weakly activated OT-1 cells (Figure 5B). As expected, we
observed that the co-optation of weakly activated OT-1 cells de-
pended on the density of strongly activated P14 cells. At low cell
density, we found that T-reg cells suppressed the co-optation of
weakly activatedOT-1T cells as efficiently as a direct blockadeof
IL-2. In contrast, the suppressive action of T-reg cells wasmostly
lost at higher densities of co-opting cells (Figure 5C). Titrating the
presentation of the strong antigen for P14 cells along with the
number of P14 cells revealed that this dependency on the density
of co-opting cells was not absolute. Indeed, we observed that
T-reg cells could suppress the inter-clonal co-optation even at
high density of co-opting cells, when these cells were stimulated
with less antigen (Figures 5D and 5E). These different observa-
tionswere found to be in good agreement withmodel predictions
(Figure 5E).CTogether, our theoretical and experimental results suggest an
alternative role for IL-2 consumption by T-reg cells: in addition to
acting on the survival and differentiation of proliferating CD8+
T cells (Kastenmuller et al., 2011; Pandiyan et al., 2007), our
data suggest that competition for IL-2 is a suppressive mecha-
nism that may also act on the initial cell-cycle entry for weakly
activated CD8+ T cells. In addition to modulating the recruitment
to APC (Pace et al., 2012), IL-2 deprivation could therefore
constitute an alternative mechanism by which T-reg cells shape
the repertoire of T cell clones and restrain the activation of low-
affinity T cells.
DISCUSSION
Our study investigated how IL-2 provided by strongly activated
T cells can synergize with the T-cell-intrinsic response to antigen
to fine-tune overall T cell activation. Weak antigens are usually
insufficient to trigger the full activation of cells through their
sole engagement of the TCR. However, the overlay of multiple
pathways into canonical signaling responses (e.g., ERK, PI3K
phosphorylation, or NFkB activation) creates the possibility for
a crosstalk between signaling responses and the cooperative
tuning of T cell activation through external stimuli.
Here, we demonstrated that a mixed population of two clones
of T cells indeed synergizes to drive the activation of the sub-
optimal clones through sharing of IL-2. Mapping experimentally
how cell decision to divide is made led us to identify PI3K activa-
tion as the key signaling response integrating TCR and IL-2R sig-
nals (Figure 2). Conventional understanding of T cell activation
would dictate that IL-2 acts as a differentiating/mitogenic signal
at intermediate or late timescales, after T cells are already fully
committed to the activated states and ready to ‘‘read’’ cytokine
cues to drive differentiation (Pipkin et al., 2010), to accelerate
cell proliferation or to abrogate apoptosis (Hart et al., 2014).
Our experiments demonstrate that blocking CD25 in the first
hours of antigen activation does abrogate the synergetic effect
of IL-2 even at times when key surface proteins associated with
activation (e.g., CD69 and CD25) have not yet been fully upregu-
lated (Figures 1F and 2E). Hence, one surprising result of our
quantitative study is that IL-2 can act during the first hours of
T cell activation and alter the threshold of antigen discrimination
(Figure 3F).
We confirmed the activation status of weakly stimulated CD8+
T cells proliferating in presence of IL-2 by comparing their expres-
sion of surface markers CD44 and CD69, transcription factors
Tbet and Eomes, as well as production of IL-2 and IFN-g to that
of strongly stimulated cells proliferatingwithout external IL-2 (Fig-
ureS2).Whereas the inductionofTbet and IFN-gwere foundcom-
parable, CD44 and CD69 were less abundant and expression of
the transcription factorEomeswas increased, indicatingabias to-
ward the memory phenotype for T cells activated with weak anti-
gens (Intlekofer et al., 2005). In agreement with observations by
other groups (Catron et al., 2006;Williams et al., 2006), our results
support a role for IL-2 inmediating the generation of a T cell mem-
ory pool originating from weakly stimulated T cells.
Our study highlights the relevance of quantitative models in
immunology in validating the sufficiency of identified molecular
mechanism to account for observed phenotypes. We built aell Reports 11, 1208–1219, May 26, 2015 ª2015 The Authors 1215
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Figure 5. T-reg Cells Can Modulate IL-2-Mediated Inter-clonal Co-optation of Weak T Cell Clones
(A) CD4+CD25+ T-reg cells were added to the in vitro co-culture system introduced in Figure 1A.
(B) Representative dot plot of CFSE and CTVMFI for live CD8+ cells after 3 days of co-culture in absence or presence of T-reg cells (isolated as CD4+CD25+ from
B6 splenocytes). OT-1 cells were stimulated by APCs pulsed with the weak agonist G4 (1 mM) in the presence of different quantities (condition 1, 103; condition 2,
105) of P14 cells stimulated by APCs pulsed with their cognate antigenGP33-41 (10 nM). Drawn gates identify P14 andOT-1 populations within live CD8+ cells, and
their respective frequencies are indicated. For each population, the percentage of cells that divided at least once is also indicated in parentheses.
(legend continued on next page)
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hybrid stochastic/deterministic model integrating TCR and IL-2R
signals at the level of PI3K activation to control cell-cycle entry.
First, we established our model for individual lymphocyte re-
sponding to cell-centered antigens and collectively shared cyto-
kines (Figure 3). Non-linearity in signal transduction coupled to
stochastic gene expression allowed to understand the source of
divergence and the tuning role of IL-2 between the decisions to
enter cell cycle or not. We then used our model to test how a
polyclonal population of cells responds collectively, under varied
stimulatory conditions such as varied precursor frequencies, var-
ied amounts of antigen, presence, or absenceof regulatory T cells
(Figure 4). Such back and forth between biochemically explicit
model and experimental validation is expanding our quantitative
understanding of the immune system (Hart et al., 2014; Tkach
et al., 2014). Future research will need to include spatio-temporal
heterogeneities that are the hallmark of cytokine communication
in vivo (whereas this study focused on establishing a well-mixed
model that matches our experimental settings in vitro).
Through the mechanism we have put forward here, weakly
self-reactive clones could be triggered into clonal expansion as
a bystander effect in other immune reactions. Our results there-
fore highlight the importance of mechanisms regulating the con-
centration of inflammatory cues, for instance via consumption by
T-reg cells, to prevent the development of autoimmune diseases
and maintain self-tolerance.
In this study, we demonstrate how heterogeneous gene
expression (in our case of IL-2Ra) can lead, albeit under the
same environmental circumstances, to different cell fates. In
the case of the immune system, such divergence of cell fates
could help maintain the diversity of the T cell repertoire in order
to cope with future unpredictable challenges. Similar behaviors
exist in other systems, such as bacterial populations, where het-
erogeneous virulence gene expression can promote the survival
of a fraction of the population against exposure to antibiotics
through a bet-edging mechanism (Deris et al., 2013). These re-
sults suggest that bi-stability in the response to environmental
cues could serve as a general strategy employed by biological
systems to cope with changing, uncertain environments.
The long-term practical impact of our study will be in the field
of immunotherapy, where expansion of the pool of T cells
involved in an immune response may be a useful tool to boost
immune responses. Based on our study, we posit that appropri-
ately timed and dosed delivery of IL-2 may constitute a valuable
approach to co-opt weak T cell clones into contributing to the(C) Distributions of the number of cell divisions per OT-1 precursor cells after 3
presented in (B) in the presence or absence of T-reg cells or IL-2 blockade. At low
stimulated OT-1 cells as efficiently as a direct block of IL-2, and this effect vanis
(D) Representation of the percentage of P14 and OT-1 precursors cells that divide
opting P14 cells and the concentration of their cognate antigen GP33–41 used to p
are indicated.
(E) The hybridmodel correctly predicts the dependency of the suppression of the i
We report the percentage of OT-1 precursor cells that divided as a function of the
GP33–41 and in the presence or absence of T-reg cells and IL-2 blockade. Model: O
model presented in Figure 3. OT-1 cells were stimulated by aweak agonist (t= 1 s)
parameter t = 10 s. For T-reg cells, no specific antigen was introduced, but we co
abundance (set here to 103 copies per cell in the basal state) of IL-2Ra character
cells per condition. For each condition, the percentage of cells that divided was es
for 3 days as in (B)–(D). Error bars represent mean ± SD for two replicates; the re
Cimmune response (e.g., against weakly antigenic tumors). Other
manipulation of the inflammatory milieu—such as delivery of
IFN-g (Richer et al., 2013) and boosting/blocking of the regula-
tory T cell compartment (Boyman et al., 2006)—will need to be
further explored to expand or limit the repertoire of T cell clones
acquiring effector function.
Overall, our study highlights how antigen discrimination by T
lymphocytes is not uniquely a cell-intrinsic property of the
signaling cascades but should be considered as the integration
of multiple cues, from the local, with the quality and quantity of
antigens, to the global, with the dynamics of accumulation of
and response to inflammatory cytokines.EXPERIMENTAL PROCEDURES
Mice, Antibodies, and Reagents
Mice
C57BL/6N (Taconic Farms), OT-1 TCR transgenic (NIAID model number 4175;
Taconic Farms) on a Rag1/ background, and LCMV-P14 TCR transgenic
mice (NIAIDmodel number 4138; Taconic Farms) were used to prepare culture
of primary lymphocytes. All micewere bred andmaintained in accordancewith
the protocol (MSKCC no. 05-12-031) approved by the institutional animal care
and use committee (IACUC) of Memorial Sloan Kettering Cancer Center.
Antigen Peptides
The LCMV-P14 TCR agonist peptide KAVYNFATM (GP33–41) and the OT-1
TCR agonist ovalbumin peptide SIINFEKL (N4), along with its variants
EIINFEKL (E1), SIIGFEKL (G4), SIIVFEKL (V4), SIITFEKL (T4), and SIIQFEKL
(Q4), were obtained from Genscript.
Antibodies
Antibodies against surface molecules CD8a (clone 53–6.7) and CD25 (IL-2Ra;
clone PC61) were purchased fromBioLegend. Antibodies against CD44 (clone
IM7) and CD69 (clone H1-2F3) were from BDBiosciences. Neutralizing anti-
bodies against mouse IL-2 (clone JES6-1A12), mouse IL-4 (clone 11B11),
and CD25 (clone PC61.5) were purchased from eBioscience and BioXCell.
Primary antibodies against phospho species phospho-p42/p44 MAPK
(pp-ERK; Thr202/Tyr204; clone E10), phospho-S6 ribosomal protein (p-S6;
Ser235/236; clone D57.2.2E) and phospho-STAT5 (p-STAT5; Tyr694; clone
C11C5) were purchased from Cell Signaling Technology. Secondary rat anti-
body against mouse IgG-APCwas purchased from Jackson ImmunoResearch
Laboratories. Secondary goat antibody against rabbit IgG F(ab’)2-PeCy7 was
purchased from Santa Cruz Biotechnology.
Small-Molecule Inhibitors
Chemical inhibitors targeting JAK (JAKi; AZD1480), MEK1/2 (MEKi; PD
0325901), and PI3K (PI3Ki; LY294002) were purchased from Selleckchem.
Other Reagents
The viability dye (Live/Dead Fixable Yellow) and amine reactive dyes CFSE
(5(6)-carboxyfluorescein diacetate N-succinimidyl ester) and CTV (Cell Trace
Violet) were purchased from Life Technologies. Recombinant human IL-2days in the in vitro co-culture system for the co-culture conditions 1 and 2
density of co-opting P14 cells, T-reg cells suppress the co-optation of weakly
hes as the density of co-opting cells increases.
d, in the presence or absence of T-reg cells, as a function of the density of co-
ulse the corresponding APCs. The conditions 1 and 2 referenced in (B) and (C)
nter-clonal co-optation by T-reg cells as a function of the co-opting cell density.
density of co-opting P14 cells for different quantities of their cognate antigen
T-1, P14, and T-reg cells were simulated simultaneously using replicates of the
. In the case of P14 cells, the cognate antigenwas taken as a strong agonist with
nsidered a high basal transcription rate of the IL-2Ra gene to generate the high
istic of this population. Simulation results shown were obtained with 104 T-reg
timated from 103 independent simulations. Experiments: cells were co-cultured
sults are representative of nR 3 independent experiments.
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and mouse IL-2, IL-4, IL-6, IL-7, IL-9, IL-15, IL-21, and IFN-g were obtained
from eBioscience. All cell cultures were prepared in complete RPMI prepared
by the MSKCC core media preparation facility (this medium contained RPMI-
1640 augmented with 10% fetal bovine serum, 10 mg/ml penicillin/strep, 2 mM
glutamine, 10 mM HEPES [pH 7.0], 1 mM sodium pyruvate, 0.1 mM non-
essential amino acids, and 50 mM b-mercaptoethanol). For flow cytometry
analysis, FACS buffer consisted of 10% fetal bovine serum (MSKCC tissue
culture core facility) and 0.1% sodium azide in PBS.
Cell Cultures
For signaling assays, OT-1 T cell cultures were prepared as follows. Irradiated
(3,000 RAD) C57BL/6N (B6) splenocytes were pulsed for 2 hr with SIINFEKL
(N4) peptide, washed once, and used as APCs. OT-1 cells were harvested
from spleen and mixed with N4-pulsed B6 splenocytes in complete RPMI. Af-
ter 2 days, cells were expanded by 2-fold dilution into complete medium with
1 nM IL-2. After 4 days, the cells were again expanded by 2-fold dilution into
complete medium with IL-2. After 1 more day of culture, cells were harvested
and spun through a 1.09-density Ficoll-Paque Plus gradient (GE Healthcare) to
remove dead cells. Live cells were recovered, washed twice in complete
medium, and resuspended at 1 million/ml in complete medium with 1 nM
IL-2. Cells were used for experiments between 6 and 8 days after primary
stimulation.
Cytokine-Signaling Assay
Live cells were purified from collected cells by separation on a Ficoll gradient.
In order to strip surface receptors from bound cytokines, cells were resus-
pended in a glycine buffer (0.1 M; pH 4.0) for 1 min on ice, washed twice in
complete RPMI, and allowed to rest for at least 30 min at 37C. Cells were
pre-incubated with small-molecule inhibitors for 15 min before stimulation. In-
hibitor concentrations were maintained at the same level during stimulation.
Cells were stimulated with 1 nM recombinant mouse IL-2 in complete RPMI
and placed on a water bath at 37C for 15 min. Cells were then directly fixed
for 10 min on ice in 2% paraformaldehyde followed by permeabilization on
ice in 90% methanol for at least 10 min. Cells were then washed twice in
FACS buffer and stained with antibodies specific for different phosphorylated
species, followed by incubation with labeled secondary antibody and conju-
gated antibodies specific for surface markers (CD8a and IL-2Ra).
Proliferation Assays
For proliferation assays, irradiated (3,000 RAD) C57BL/6 splenocytes were
used as APCs. APCs were pulsed for 2 hr with a given peptide before being
washed extensively in complete RPMI. Responder OT-1 and P14 cells were
harvested from spleen and stained with 2.5 mM of CTV and CFSE, respec-
tively. CD8a+ P14 cells were then isolated using antibody-coupled magnetic
beads (Miltenyi Biotec) and the percentage of CD8a+ OT-1 and P14 cells was
measured on a LSRII instrument (BD Bioscience). Unless otherwise indicated,
for a given responder cell type, 105 CD8a+ responder cells were stimulated
with 2.5 3 105 APCs pulsed with 1 mM of the corresponding peptide per
well of a 96 V bottom plate (Thermo Scientific). In the case where T-reg cells
are present, 105 CD4+CD25+ cells isolated from C57BL/6N splenocytes us-
ing magnetic beads (Miltenyi Biotec) were added. Indicated cytokines (1 nM
unless otherwise indicated), blocking antibodies (4 mg/ml), and chemical in-
hibitors were then added to reach a final volume of 200 ml per well. Contacts
between T cells and APCs were synchronized using a quick centrifugal spin
(10 s at 450 g) before incubation at 37C. After the indicated incubation
period, cells were washed in PBS and stained with a viability dye (Live/
Dead Yellow). Cells were then resuspended in FACS buffer and stained for
surface markers. Fluorescence was then acquired on a LSRII instrument
(BD Bioscience).
Quantification of Precursor Cell Number
P14 and OT-1 cells were identified among live CD8a+ cells based on the GMFI
of CFSE and CTV using the FlowJo software. The number of cell divisions
experienced by a cell of a given type was obtained from the dilution profile
of the corresponding dye. The number of cells having experienced k divisions
until the time of observation tobs, denoted Nk, was obtained using gates
defined around identified peaks in the distribution of the corresponding dye.1218 Cell Reports 11, 1208–1219, May 26, 2015 ª2015 The AuthorsAssuming a uniform and constant doubling period T, the number of precursor
cells that divided k times was estimated as NPk = Nk/2
k. The corresponding
time of first division was then computed as tstart = tobs  k*T. At the time of
observation tobs, the percentage of cells that divided at least once is given
by (Sk > 0 NPk)/(Sk NPk).
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